Similar Search Results

The Double-Edged Sword of Health Care Integration : Consolidation and Cost Control

Fuse Brown, Erin C. - 2017

together disparate providers from hospitals to physicians - is a double-edged sword, with the potential to reduce wasteful and …

Persistent link: https://www.econbiz.de/10012969976

Regulated Competition on Health Insurance Markets : Budget Balancing, Opt-out and Price Caps

Schickner, Benjamin - 2017

This paper studies redistributional effects of competition between private and public insurance on health insurance markets based on the example of Germany. Health insurance is provided by a budget-balancing public insurance and a revenue-maximizing private insurance; customers are characterized...

Persistent link: https://www.econbiz.de/10012970738

Risk Adjustment Revisited Using Machine Learning Techniques

Riascos, Alvaro - 2017

Risk adjustment is vital in health policy design. Risk adjustment defines the annual capitation payments to health insurers and is a key determinant of insolvency risk for health insurers. In this study we compare the current risk adjustment formula used by Colombia's Ministry of Health and...

Persistent link: https://www.econbiz.de/10012955688

Does Defensive Medicine Reduce Health Care Spending?

Barkowski, Scott - 2015

, however, has ignored the fact that physicians face risk from industry oversight groups like state-level medical licensing … punishments by oversight groups against physicians, known as adverse actions, along with malpractice payments data to study state … associated with statistically significant average annual spending decreases in hospital care and prescription drugs of as much as …

Persistent link: https://www.econbiz.de/10013019800

Technological Change and Risk Adjustment : Benefit Design Incentives in Medicare Part D

Carey, Colleen Marie - 2015

Subsidized health insurance markets use diagnosis-based risk adjustment to induce insurers to offer an equitable benefit to individuals of varying expected cost. I demonstrate that technological change after risk adjustment calibration -- new drug entry and the onset of generic competition --...

Persistent link: https://www.econbiz.de/10013033922

Drug Rebates Do Not Increase Costs to Consumers

Lo Sasso, Anthony T. - 2018

Ascribing a portion of the blame for high drug prices on the system of manufacturer rebates misconstrues the nature of the market for prescription drugs. We submit that these rebates are the product of a healthy negotiating process between pharmacy benefit managers and manufacturers, one that...

Persistent link: https://www.econbiz.de/10012917935

Health Expenditure in Italy : A Comprehensive Intergovernmental Model

Pammolli, Fabio - 2018

The paper provides an analysis of the determinants of health spending differentials among the Italian Regions for the years 1998-2010. An original standardised spending framework is proposed that takes into account the appropriateness of the services provided and price/technical efficiency, as...

Persistent link: https://www.econbiz.de/10012918504

Coinsurance vs. Copayments : Reimbursement Rules for a Monopolistic Medical Product with Competitive Health Insurers

Cremer, Helmuth; Lozachmeur, Jean-Marie - 2021

This paper studies a market for a medical product in which there is perfect competition among health insurers, while the good is sold by a monopolist. Individuals differ in their severity of illness and there is ex post moral hazard. We consider two regimes: one in which insurers use coinsurance...

Persistent link: https://www.econbiz.de/10013221173

The Henry Fords of Healthcare

Sanandaji, Nima - 2021

. Healthcare organisation gives each local hospital the task of treating broad ranges of conditions, which makes high levels of …

Persistent link: https://www.econbiz.de/10013225492

Novel Health Insurance Plan for Low Resource Countries : Medical Complication Insurance (MCI) Based on Sandesh-Triple Insurance (S-TI) Concept

Shet, Dr U Sandesh - 2021

Medical care is associated with unexpected complications increasing the treatment cost causing financial burden on the patient especially when the patient doesn’t have a health insurance or when the treatment cost exceeds the sum insured limit of a health policy. A novel insurance plan –...

Persistent link: https://www.econbiz.de/10013235690